|
- CEPI
CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats
- About CEPI
CEPI's mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need
- Our approach - CEPI
CEPI is working to substantially reduce global epidemic and pandemic risk by delivering innovative, access-focussed R D programmes that help the world accelerate the development of safe, effective and globally accessible vaccines to 100 days—referred to as the 100 Days Mission
- Calls for Proposals - CEPI
We’ll also provide you with some guidance and recommendations on your project and a potential application to one or more of CEPI’s Calls We are particularly interested in hearing from vaccine developers and researchers in the Global South
- CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic . . .
The Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $54 3 million to support a pivotal Phase 3 clinical trial that aims to help advance Moderna’s investigational mRNA-based H5 pandemic influenza vaccine candidate, mRNA-1018, to licensure
- CEPI 2. 0 and the 100 Days Mission
CEPI’s 2022-2026 strategy, known as CEPI 2 0, is helping to Prepare, Transform, and Connect the world so that it can respond to the next Disease X by accelerating the development of safe, effective, globally accessible vaccines in as little as 100 days
- News - CEPI
Keep up-to-date on the latest announcements and updates from CEPI and our global partners
- Why we exist - CEPI
CEPI was launched at Davos in 2017 as the result of a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics
|
|
|